New concepts in chronic urticaria

Current Opinion in Immunology

Volumn 20, Issue 6, 2008, Pages 709-716

  Vonakis, Becky M ^a   Saini, Sarbjit S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; AUTOANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G;

BASOPHIL; CELL INFILTRATION; CHRONIC URTICARIA; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTAMINE RELEASE; HISTOPATHOLOGY; HUMAN; LYMPHOCYTE; MAST CELL; PATHOGENESIS; REMISSION; REVIEW; SEROLOGY; SKIN BIOPSY; SKIN MANIFESTATION; WESTERN BLOTTING;

AUTOANTIBODIES; BASOPHILS; CHRONIC DISEASE; CYTOKINES; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LYMPHOCYTES; MAST CELLS; RECEPTORS, IGE; RECEPTORS, IGG; URTICARIA;

EID: 56349121140     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.09.005     Document Type: Review

References (78)

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol 105 (2000) 664-672
2. Kaplan A.P. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 114 (2004) 465-474. This is a general review that discusses the current understanding of autoimmune hypothesis of CIU.
3. Toubi E., Kessel A., Avshovich N., Bamberger E., Sabo E., Nusem D., and Panasoff J. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 59 (2004) 869-873
4. Morgan M., and Khan D.A. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 100 (2008) 403-412. This is a timely review of the current immunomodulators used for CIU.
5. Grob J.J., Revuz J., Ortonne J.P., Auquier P., and Lorette G. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 152 (2005) 289-295
6. O'Donnell B.F., Lawlor F., Simpson J., Morgan M., and Greaves M.W. The impact of chronic urticaria on the quality of life. Br J Dermatol 136 (1997) 197-201
7. Delong L.K., Culler S.D., Saini S.S., Beck L.A., and Chen S.C. Annual direct and indirect costs of chronic idiopathic urticaria: a cost analysis of fifty non-immunocompromised patients. Arch Dermatol 144 (2008) 35-39
8. Smith C.H., Kepley C., Schwartz L.B., and Lee T.H. Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 96 (1995) 360-364
9. Jacques P., Lavoie A., Bedard P.M., Brunet C., and Hebert J. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol 89 (1992) 1139-1143
10. Cohen R.W., and Rosenstreich D.L. Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J Allergy Clin Immunol 77 (1986) 802-807
11. Ying S., Kikuchi Y., Meng Q., Kay A.B., and Kaplan A.P. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 109 (2002) 694-700. This is a detailed description of the cellular infiltrate found in CIU subjects with and without HRA.
12. Sabroe R.A., Poon E., Orchard G.E., Lane D., Francis D.M., Barr R.M., Black M.M., Black A.K., and Greaves M.W. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Allergy Clin Immunol 103 (1999) 484-493
13. Caproni M., Volpi W., Macchia D., Giomi B., Manfredi M., Campi P., Cardinali C., D'Agata A., and Fabbri P. Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test. Exp Dermatol 12 (2003) 621-628
14. Gruber B.L., Baeza M.L., Marchese M.J., Agnello V., and Kaplan A.P. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 90 (1988) 213-217
15. Hide M., Francis D.M., Grattan C.E., Hakimi J., Kochan J.P., and Greaves M.W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328 (1993) 1599-1604
16. Brodell L.A., Beck L.A., and Saini S.S. Pathophysiology of chronic urticaria. Ann Allergy Asthma Immunol 100 (2008) 291-297
17. Sheikh J. Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they?. Curr Opin Allergy Clin Immunol 5 (2005) 403-407
18. Grattan C.E., Dawn G., Gibbs S., and Francis D.M. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 33 (2003) 337-341
19. Caproni M., Giomi B., Volpi W., Melani L., Schincaglia E., Macchia D., Manfredi M., D'Agata A., and Fabbri P. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. Clin Immunol 114 (2005) 284-292
20. Grattan C.E., Walpole D., Francis D.M., Niimi N., Dootson G., Edler S., Corbett M.F., and Barr R.M. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 27 (1997) 1417-1424
21. Charlesworth E.N., Kagey-Sobotka A., Schleimer R.P., Norman P.S., and Lichtenstein L.M. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 146 (1991) 671-676
22. Greaves M.W., Plummer V.M., McLaughlan P., and Stanworth D.R. Serum and cell bound IgE in chronic urticaria. Clin Allergy 4 (1974) 265-271
23. Kern F., and Lichtenstein L.M. Defective histamine release in chronic urticaria. J Clin Invest 57 (1976) 1369-1377. This is the first report to describe that the suppression of the IgE receptor pathway in active CIU subjects improves in disease remission.
24. Sabroe R.A., Francis D.M., Barr R.M., Black A.K., and Greaves M.W. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 102 (1998) 651-658
25. Luquin E., Kaplan A.P., and Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 35 (2005) 456-460
26. Vonakis B.M., Vasagar K., Gibbons Jr. S.P., Gober L., Sterba P., Chang H., and Saini S.S. Basophil FceRI histamine release parallels expression of Src-homology2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol 119 (2007) 441-448. Discussed the distinct basophil functional phenotypes in CIU and the associated signaling changes.
27. Zhang J., Berenstein E.H., Evans R.L., and Siraganian R.P. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med 184 (1996) 71-79
28. Kepley C.L., Youssef L., Andrews R.P., Wilson B.S., and Oliver J.M. Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 104 (1999) 279-284
29. Macglashan D., and Miura K. Loss of syk kinase during IgE-mediated stimulation of human basophils. J Allergy Clin Immunol 114 (2004) 1317-1324
30. Macglashan Jr. D.W. Relationship between spleen tyrosine kinase and phosphatidylinositol 5′ phosphatase expression and secretion from human basophils in the general population. J Allergy Clin Immunol 119 (2007) 626-633. This study describes the relevant molecules regulating histamine release in normal basophils.
31. Harris S.J., Parry R.V., Westwick J., and Ward S.G. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes. J Biol Chem 283 (2008) 2465-2469
32. Kimura T., Sakamoto H., Appella E., and Siraganian R.P. The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated beta subunit of the high affinity IgE receptor. J Biol Chem 272 (1997) 13991-13996
33. Gimborn K., Lessmann E., Kuppig S., Krystal G., and Huber M. SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels. J Immunol 174 (2005) 507-516
34. Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., and Krystal G. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci U S A 95 (1998) 11330-11335
35. Vonakis B.M., Gibbons Jr. S., Sora R., Langdon J.M., and MacDonald S.M. Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J Allergy Clin Immunol 108 (2001) 822-831
36. Gibbs B.F., Rathling A., Zillikens D., Huber M., and Haas H. Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J Allergy Clin Immunol 118 (2006) 1060-1067
37. Leung W.H., and Bolland S. The inositol 5′-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J Immunol 179 (2007) 95-102
38. Vonakis B.M., and Saini S.S. Syk-deficient basophils from donors with chronic idiopathic urticaria exhibit a spectrum of releasability. J Allergy Clin Immunol 121 (2008) 262-264
39. Eckman J., Hamilton R.G., Gober L.M., Sterba P.M., and Saini S.S. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol 128 (2008) 1956-1963. This study provides evidence of the stability of basophil phenotypes in active CIU subjects, their shift in disease remission and independence from the presence of autoantibodies. Further shows the similar frequency and titer of autoantibodies in CIU and non-CIU subjects.
40. Baker R., Vasagar K., Ohameje N., Gober L., Chen S.C., Sterba P.M., and Saini S.S. Basophil histamine release activity and disease severity in chronic idiopathic urticaria. Ann Allergy Asthma Immunol 100 (2008) 244-249
41. Lourenco F.D., Azor M.H., Santos J.C., Prearo E., Maruta C.W., Rivitti E.A., Duarte A.J., and Sato M.N. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br J Dermatol 158 (2008) 979-986
42. Vasagar K., Vonakis B.M., Gober L., Viksman A., Gibbons Jr. S.P., and Saini S.S. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy 36 (2006) 770-776
43. Confino-Cohen R., Aharoni D., Goldberg A., Gurevitch I., Buchs A., Weiss M., Weissgarten J., and Rapoport M.J. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 109 (2002) 349-356
44. Ferrer M., Luquin E., Sanchez-Ibarrola A., Moreno C., Sanz M.L., and Kaplan A.P. Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol 129 (2002) 254-260
45. Dos Santos J.C., Azor M.H., Nojima V.Y., Lourenco F.D., Prearo E., Maruta C.W., Rivitti E.A., da Silva Duarte A.J., and Sato M.N. Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int Immunopharmacol 8 (2008) 1433-1440
46. Confino-Cohen R., Goldberg A., Aharoni D., Naiman L., Buchs A., Weiss M., Weissgarten J., and Rapoport M.J. Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria. Cytokine 27 (2004) 74-80
47. Piconi S., Trabattoni D., Iemoli E., Fusi M.L., Villa M.L., Milazzo F., and Clerici M. Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol 128 (2002) 59-66
48. Kambe N., Kambe M., Kochan J.P., and Schwartz L.B. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97 (2001) 2045-2052
49. Gomez G., Jogie-Brahim S., Shima M., and Schwartz L.B. Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc epsilonRI on human skin mast cells. J Immunol 179 (2007) 1353-1361
50. O'Donnell B.F., O'Neill C.M., Francis D.M., Niimi N., Barr R.M., Barlow R.J., Kobza Black A., Welsh K.I., and Greaves M.W. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 140 (1999) 853-858
51. Sabroe R.A., and Greaves M.W. Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol 154 (2006) 813-819
52. Sabroe R.A., Seed P.T., Francis D.M., Barr R.M., Black A.K., and Greaves M.W. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 40 (1999) 443-450
53. Sabroe R.A., Fiebiger E., Francis D.M., Maurer D., Seed P.T., Grattan C.E., Black A.K., Stingl G., Greaves M.W., and Barr R.M. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 110 (2002) 492-499
54. Fusari A., Colangelo C., Bonifazi F., and Antonicelli L. The autologous serum skin test in the follow-up of patients with chronic urticaria. Allergy 60 (2005) 256-258
55. Mari A. Allergy-like asthma and rhinitis. A cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test. Int Arch Allergy Immunol 133 (2004) 29-39. This study identifies the presence of ASST positivity in non-CIU populations.
56. Guttman-Yassky E., Bergman R., Maor C., Mamorsky M., Pollack S., and Shahar E. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. J Eur Acad Dermatol Venereol 21 (2007) 35-39
57. Fagiolo U., Kricek F., Ruf C., Peserico A., Amadori A., and Cancian M. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 106 (2000) 567-572
58. Grattan C.E., Francis D.M., Hide M., and Greaves M.W. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 21 (1991) 695-704
59. Asero R., Tedeschi A., Riboldi P., Griffini S., Bonanni E., and Cugno M. Coagulation cascade and fibrinolysis in patients with multiple-drug allergy syndrome. Ann Allergy Asthma Immunol 100 (2008) 44-48
60. Soundararajan S., Kikuchi Y., Joseph K., and Kaplan A.P. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 115 (2005) 815-821
61. Kikuchi Y., and Kaplan A.P. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109 (2002) 114-118
62. Kikuchi Y., and Kaplan A.P. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 107 (2001) 1056-1062
63. Yasnowsky K.M., Dreskin S.C., Efaw B., Schoen D., Vedanthan P.K., Alam R., and Harbeck R.J. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 117 (2006) 1430-1434
64. Fiebiger E., Hammerschmid F., Stingl G., and Maurer D. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 101 (1998) 243-251
65. Bobrzynski T., Fux M., Vogel M., Stadler M.B., Stadler B.M., and Miescher S.M. A high-affinity natural autoantibody from human cord blood defines a physiologically relevant epitope on the FcepsilonRIalpha. J Immunol 175 (2005) 6589-6596
66. Bingham Iii CO. Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease. Curr Allergy Asthma Rep 8 (2008) 278-287. This is an excellent review of novel immunomodulators with potential to benefit CIU subjects.
67. Saini S.S., and MacGlashan D. How IgE upregulates the allergic response. Curr Opin Immunol 14 (2002) 694-697
68. Meltzer E.O., Berkowitz R.B., and Grossbard E.B. An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment. J Allergy Clin Immunol 115 (2005) 791-796
69. Beck L., Marcotte G., MacGlashan Jr. D.W., Togias A., and Saini S. Omalizumab induced reductions in mast cell FceRI expression and function. J Allergy Clin Immunol 114 (2004) 527-530
70. Kawakami T., and Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J Immunol 175 (2005) 4167-4173
71. Xie L., Schroeder J.T., Langdon J.M., Sora-Scott R.S., Kawakami T., and MacDonald S.M. Human IgE+ and IgE- are not equivalent to mouse highly cytokinergic IgE. J Allergy Clin Immunol 121 (2008) 1027-1033
72. Spector S.L., and Tan R.A. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 99 (2007) 190-193
73. Gober L., Sterba P., Eckman J., and Saini S. Effect of anti-IgE (omalizumab) in chronic idiopathic urticaria patients. J Allergy Clin Immunol 121 (2008) S147. This is a placebo-controlled study of omalizumab in CIU.
74. Kaplan A.P., Joseph K., Maykut R.J., and Zeldin R.K. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 122 (2008) 569-573. This is a controlled trial of omalizumab in ASST positive subjects.
75. Rossi A.B., Herlaar E., Braselmann S., Huynh S., Taylor V., Frances R., Issakani S.D., Argade A., Singh R., Payan D.G., et al. Identification of the Syk kinase inhibitor R112 by a human mast cell screen. J Allergy Clin Immunol 118 (2006) 749-755
76. Ong C.J., Ming-Lum A., Nodwell M., Ghanipour A., Yang L., Williams D.E., Kim J., Demirjian L., Qasimi P., Ruschmann J., et al. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 110 (2007) 1942-1949
77. VanMeter A., Signore M., Pierobon M., Espina V., Liotta L.A., and Petricoin III E.F. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine. Expert Rev Mol Diagn 7 (2007) 625-633
78. Saini S, Paterniti M, Vasagar K, Gibbons SC Jr., Sterba PM, Vonakis BM, Cultured mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: relationship to expression of Syk and SHIP-2, submitted for publication.